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Summary. 72As-labelled radiopharmaceuticals could be
a valuable resource for Positron Emission Tomography (PET).
In particular, the long half-life of 72As (T1/2 = 26 h) facili-
tates the observation of long-term physiological or metabolic
processes, such as the enrichment and distribution of an-
tibodies in tumor tissue. This work describes the primary
radiochemical separation of no-carrier-added (nca) 72Se from
cyclotron irradiated germanium targets and the development
of a polystyrene type solid-phase extraction based 72Se/72As
radionuclide generator, avoiding the addition of any selenium
carrier. The irradiated germanium target is dissolved in HFconc
and selenium is reduced with hydrazine dihydrochloride. The
nca 72Se(0) is adsorbed on a solid-phase extraction cartridge,
representing the generator column. The 72As is eluted using
various aqueous solvents with 40%–60% yield and < 0.1%
72Se content. To be able to study the radiopharmaceutical ar-
senic chemistry, subsequent chemical modification of the nca
72As eluates to nca [72As]AsI3 provides a versatile radioarsenic
labelling synthon.
1. Introduction
The recent increasing interest in the element arsenic in en-
vironmental sciences [1], toxicology and carcinogenesis [2]
and medicine [3, 4] stimulates development of convenient
and reproducible methods to trace this element and its com-
pounds in subtoxic and subpharmaceutical concentrations.
Arsenic has several isotopes of interest for medical or envi-
ronmental application (cf. Table 1).
A number of approaches to develop an easy and practi-
cal system to separate these arsenic isotopes from cyclotron
or reactor irradiated germanium or germanium oxide tar-
gets have been described [5–8]. In parallel, a 72Se/72As
radionuclide generator has been studied [9–15]. Strategies
towards a versatile radioarsenic labelling chemistry were de-
veloped to generate arsenic isotopes in chemical forms suit-
able for future application in labelling chemistry, radiophar-
macy and, ultimately, for molecular imaging using Positron
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Emission Tomography (PET). Recent advances in the use
of 74As labelled antibodies, directed against the apoptotic
marker phophatidylserine (PS) in a Dunning R2337 AT1
prostate cancer model [16], clearly demonstrate the potential
of those radioarsenic isotopes. This enhances the motivation
to develop adequate and reliable radiochemical separations.
72As is a positron emitting arsenic isotope, with proper-
ties suitable for possible application in 72As-labelled PET-
radiopharmaceuticals. It has a positron emission rate of
88% with Eβ+max = 2.5 MeV and Eβ+mean = 1.2 MeV [17].
Although the positron emission is accompanied by the
emission of photons of 834 keV (79.5%), 630 keV (7.9%),
1461 keV (1.1%) and others (< 0.5%), the long physical
half-life of 26 hours may render 72As as a PET radionuclide
of choice for the quantitative imaging of biochemical and
physiological processes with longer biological half-lives,
e.g. immunoimaging and receptor mapping. In those cases,
the half-life of 72As is commensurate with the radiopharma-
cological requirements resulting from the slower localiza-
tion kinetics of the labelled species. These advantages are
comparable to those expected from 124I (T1/2 = 4.18 d), but
note that that radionuclide has a β+ branching of 22% only.
On the other hand, compared to established radiohalogena-
tion strategies, a versatile chemistry of arsenic is required to
permit the radiolabelling of a broad spectrum of potentially
valuable pharmaceuticals.
In addition to direct production routes, the radionuclide
72As can be obtained as a daughter of the relatively long-
lived 72Se (T1/2 = 8.5 d). Various methods for the production
of 72Se have been described, but mainly in the context of
73Se production [18–22]. The deuteron- and proton-induced
reactions on arsenic, and α- and 3He-induced reactions on
germanium have been investigated. Alternatively, 72Se can
be obtained via proton induced spallation of e.g. RbBr [11].
Radionuclide generator systems play a key role in provid-
ing both diagnostic and therapeutic radionuclides for various
applications in nuclear medicine, oncology and interven-
tional cardiology. In particular, centers lacking a cyclotron to
produce the necessary radionuclides might benefit substan-
tially from the availability of biomedical PET radionuclide
generators [15]. Several 72Se/72As generator systems have
been proposed previously. Al-Kouraishi and Boswell [9]
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72As 73As 74As 76As 77As
T1/2 [d] 1.1 80.3 17.8 1.1 1.6
Mode of decay [%] EC (12.2) EC (100) EC (71) β− (100) β− (100)
β+ (87.8) β+ (29.0)
Most abundant 834.0 (79.5) 53.4 (10.0) 595.8 (59.0) 559.1 (45.0) 239.0 (1.6)
γ -rays [keV]
Intensity in (%) 629.9 (7.9) 657.1 (6.2)
Table 1. Most interesting radioisotopes of
arsenic and their decay data [24].
eluted 72As from a coagulated form of carrier-added 72Se on
a Dowex 50 column in 15 ml of water. Electrolytic gener-
ators with 72Se deposited on Pt electrodes as Cu72Se were
reported [12, 13]. Another process using addition of selen-
ium carrier in the form of selenic acid uses the cyclic reduc-
tion of selenium to Se(0) and a separation of 72As by filtration
with subsequent oxidative dissolution of Se(0) using H2O2
prior to each separation cycle [11]. As published recently,
our group developed a no-carrier-added generator based on
distillation [10, 23]. Following the Ge(3He, 3n)72Se process,
the irradiated Ge was dissolved in aqua regia and germa-
nium was removed via distillation as GeCl4. The remaining
solution of 72Se in conc. HCl was transferred to a vertical
quartz tube device. In the presence of various chloride salts
in the 72Se solution, no-carrier-added 72As was nearly quan-
titatively released within 10 min at temperatures of 100 ◦C in
an HCl gas flow.
The aim of this work was to develop a 72Se/72As genera-
tor, still without any addition of selenium carrier, but which
should be more practicable and convenient compared to pre-
viously published systems. Moreover, transfer of the sepa-
rated and purified 72As fraction to a chemical form (synthon)
optimum for future labelling chemistry should represent an
important feature of the radionuclide generator system to
allow investigations of 72As-labelled radiopharmaceuticals.
The system should be reliable for the routine separation of
72As, and finally, the handling time should be reduced to
a minimum.
2. Experimental
2.1 Isotope production
72Se was produced at the compact cyclotron CV28 at the
Forschungszentrum Jülich via the natGe (3He, 3n) nuclear
reaction. Irradiation was done with 36 MeV 3He-particles
at a beam current of 5 µA for 12 h, giving a yield of
about 185 MBq (3.1 MBq/mAh). 72Se was also produced
via the 70Ge(α, 2n)72Se reaction with a bombarding en-
ergy of 36.5 MeV. The beam current was 4.5 µA and ir-
radiations of 5 h resulted in an activity of about 185 MBq
(8.2 MBq/mAh). All irradiations were performed on natural
or isotopically enriched germanium or on natural germa-
nium oxide.
2.2 Radiochemical separation of 72 Se
and generator setup
To isolate 72Se from the irradiated germanium targets,
100 mg of irradiated metallic germanium is dissolved in
5 ml HFconc and 500 µl HNO3 conc at room temperature
within 3 hours. The amount of HNO3 conc necessary could
be reduced with a prolonged dissolution period, e.g. to
50 µl, if the target is stirred overnight in 5 ml HFconc
prior to the addition of the oxidizing acid. Germanium
oxide targets can be dissolved directly in 5 ml HFconc
without using HNO3. The subsequent procedures are per-
formed analogously. In order to reduce Se(VI) to Se(0),
10 mg of hydrazine dihydrochloride or SO2 is added to the
solution.
A polystyrene based (Varian ENV, 500 µl bed volume)
solid phase extraction cartridge is preconditioned with 5 ml
of CH3OH, 5 ml H2O and 5 ml HFconc before the mixture is
transferred to the cartridge. While macroscopic Ge is eluted
with the mobile phase as [GeF6]2−, 72Se(0) is adsorbed on the
solid phase, thus becoming the generator column. After first
setup of the generator column, the remaining HF is removed
with N2 and the cartridge is stored in a sealed container in N2
atmosphere for the next elution.
2.3 Elution of nca 72 As from the nca 72 Se loaded
generator cartridge
The generated daughter 72As can be subsequently eluted
using various aqueous solvents. In this work, HF, aqua re-
gia, pure H2O, 0.1 and 1.0 molar NaOH and MeOH/H2O
gradients have been used to find the optimum elution
conditions. The effect of various liquids and/or gases
under which the generator is stored between two suc-
cessive elutions was studied. The generators were eluted
daily and every 48 h. Fractions of 100 µl were collected
and 72As and 72Se contents were determined using γ -ray
spectroscopy.
2.4 Reaction to produce 72 AsI3
The combined eluate fractions (V = 2 ml) are diluted with
3 ml HFconc at room temperature in a Teflon flask contain-
ing 10 mg of KI. The solution is stirred for 10–15 minutes,
until it develops a slight yellowish colour. The mixture is
then transferred to a second, identical ENV-solid phase ex-
traction cartridge preconditioned with 5 ml of MeOH, 5 ml
H2O and 5 ml HFconc containing potassium iodide at a con-
centration of 1 mg/ml. The nca [72As]AsI3 is absorbed on
that cartridge. Subsequently, [72As]AsI3 can be eluted with
ethanol or other organic solvents. Some following chemistry
may require a water-free environment. In this case, the nca
[72As]AsI3 can be eluted with chloroform and dried with
CaCl2 before further reactions.
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2.5 Determination of radionuclidic purity
and radiochemical separation yields
Radionuclidic purity and radiochemical separation yields
were obtained using γ -ray spectroscopy. Aliquots of the
dissolved target were measured and quantitatively com-
pared with the γ -ray spectra of the loaded generator, elu-
ates and waste solutions. The γ -ray spectroscopy was per-
formed using an ORTEC high-purity germanium detector
system and the Gamma Vision 5.0 software by ORTEC
for analysis.
2.6 Materials
Metallic germanium (99.9999% grade) and germanium(IV)-
oxide (99.9999% grade, PURA TREM) were purchased
from Strem Chemicals Inc.. Concentrated hydrofluoric acid
(48%) and potassium iodide were purchased from Aldrich.
BOND ELUT ENV solid phase extraction cartridges with
a bed volume of 500 ml were purchased from Varian. Iso-
topically enriched germanium was purchased from Campro
Scientific, with 96.4% 72Ge content.
3. Results and discussion
3.1 Separation of 72 Se
The radiochemical procedure used to separate nca 72Se from
irradiated germanium targets (natural or isotopically en-
riched) is based on the formation of soluble [GeF6]2− in
concentrated hydrofluoric acid and the reduction of 72Se to
72Se(0) by hydrazine. This reduction is a standard reaction
for the gravimetric estimation of macroscopic selenium (IV)
and (VI) in aqueous solutions, cf. e.g. [23].
H2SeO3 +N2H4 → Se+3H2O+N2
Other reducing agents described are sulphur dioxide or
tin(II) chloride [23]. In order to avoid addition of other
metals, we evaluated only sulphur dioxide and hydrazine
dihydrochloride. Both approaches gave comparable sepa-
ration yields of 98± 2% nca 72Se. However, SO2 causes
a significant loss (> 30%) of 72Se-activity, due to volatiliza-
tion together with excess sulphur dioxide, which was not
observed while using hydrazine dihydrochloride as the re-
ducing agent.
The oxidation state of the target material is important.
The use of GeO2 is preferable, since macroscopic Ge is
already in the oxidation state +IV. However, to date isotopi-
cally enriched germanium as target material is only available
as metal. Thus while using metallic germanium as target ma-
terial, besides HF small amounts of HNO3 have to be added
to oxidise Ge(0) to Ge(IV) and to dissolve the target. Heat-
ing the mixture accelerates the dissolution significantly, but
it also results in some loss of selenium, as under these con-
ditions the volatile SeF4 is formed. The formation of SeF4
(Tb = 100 ◦C) is negligible at room temperature. A com-
parison of the the γ -ray spectroscopically measured 72Se
contents of the target solution before and after reduction, and
before and after solid-phase extraction, indicate separation
yields > 95% for 72Se using hydrazine dihydrochloride. The
amount of Ge separated from the initial cartridge is > 99%.
3.2 72 Se/72 As radionuclide generator
From the transient radionuclide generator kinetics, the time
during which the daughter activity reaches the maximum
is calculated to be 88.6 h. However, after 48 h, i.e. every
second day, it is theoretically possible to elute about 75%
of the maximum daughter activity (∼ 40% to elute every
24 h) [10]. Fig. 1 shows a γ -ray spectrum in linear scale
of the loaded generator at equilibrium. The characteris-
tic γ -lines of 72As, besides the 511 keV annihilation radi-
ation, are 834.0 keV (79.5%) and 629.9 keV (7.92%). 72Se
can only be identified by its low energy γ -ray at 46.0 keV
(58.0%).
The radiochemical separation yields were evaluated as
a function of different solvents for the elution of the daugh-
ter activity over a wide pH range. From the individual γ -
ray spectra of each aliquot, the peak areas for 72As and
72Se were determined before and after each separation step.
Table 2 shows the 72As yield and 72Se breakthrough for
4 eluents.
Deionized water as eluent gives the highest 72As separa-
tion yield of 60%. The breakthrough of the mother radionu-
clide is minimum when eluting with HFconc, however, the
72As yield of 50% is significantly lower than with the deion-
ized water. A change of pH using NH3 or phosphoric acid
as eluent does not increase the 72As elution yield. To keep
the eluate volume small, the generator was eluted with a vol-
ume of 1 ml, irrespective of the solvent. Higher yields could
be obtained with larger volumes (comparable to the volume
of 15 ml used by Al-Kourashi and Boswell [9]), but a higher
volume could result in difficulties during the subsequent la-
belling chemistry.
Table 2. 72As yield and 72Se breakthrough for 4 types of eluents [V =
2 ml].
Eluent 72As yield 72Se breakthrough
(%) (%)
HFconc 50±5 < 0.1
H2O 60±5 1.9
NH3, 1.3%, pH = 11.5 30±5 0.4
Phosphoric acid, 1.3%, pH = 0.5 30±5 1.2
Fig. 1. γ -ray spectrum of a 100 µCi 72Se/72As radionuclide generator
before elution.
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The initial content of 72Se in the generator eluate is rel-
evant for a possible medical application. However, there are
two further processing steps to consider, namely (a) forma-
tion of [72As]AsI3 including an ENV cartridge separation
process, and (b) final labelling of the biomolecules of inter-
est with [72As]AsI3. Both processes will further reduce the
level of 72Se in the final 72As fractions. This further reduc-
tion is 5fold for process (a), as selenium generally does not
react with iodides [23].
Thus, the 72Se breakthrough appears to be more relevant
in terms of the overall 72Se/72As generator activity. By an
average breakthrough of 1% the generator load losses are
negligible compared to the loss by the decay of 72Se. There-
fore, we suggest choosing the eluent based on the solvent-
requirements for the following experiments.
Fig. 2 shows a typical elution profile of a 100 µCi
72Se/72As isotope generator, eluted with HFconc. The daugh-
ter activity concentration has its maximum after 200 µl and
it is possible to elute the whole activity in 500 µl.
The radionuclidic purity of the eluted 72As was deter-
mined via γ -ray spectroscopy of the eluted fraction (Fig. 3).
All the peaks are attributed to 72As. The 46 keV γ -ray from
72Se is not detectable after 1 h measurement time. Using
these spectroscopic data, the 72Se-breakthrough was calcu-
lated to be less than 0.1%.
The radiochemical purity is very much dependent on the
storage conditions of the generator between subsequent elu-
tions. The reduced Se(0) on the cartridge is sensitive to ox-
idation. In the case that the generator is stored also under
HFconc, but under air instead of nitrogen for 2 days without
elution, up to 10% of the 72Se load breaks through. This can
be avoided by removing excess HFconc with nitrogen after
elution, and storing the generator in a sealed nitrogen-filled
container. Another option is to store the generator column
under reducing conditions filled with 0.1 M hydrazine di-
hydrochloride containing HFconc solution. While this option
works well for the development of radiochemical processes,
hydrazine dihydrochloride might interfere when the eluted
activity is used for subsequent chemical reactions.
Fig. 2. Typical elution profile of a 100 µCi 72Se/72As radionuclide gen-
erator (eluted with HFconc; percentage of eluted activity is based on
the activity summation of the combined fractions, total elution volume
2 ml).
Fig. 3. γ -ray spectrum of eluted 72As, shown on a logarithmic scale.
3.3 Conversion to [72 As]AsI3
The eluted 72As activity reacts on addition of potassium
iodide and forms [72As]AsI3. This process can also be ob-
served when adding macroscopic amounts of As2O3 and KI
to a HF solution. The bright orange AsI3 is immediately pre-
cipitated. The yield for the cold reaction is > 95%. Elution
with HF has the advantage that [72As]AsI3 is soluble in or-
ganic solvents and therefore can easily be separated from
the HFconc solution by liquid-liquid or solid phase extraction.
The formation of [72As]AsI3 transforms the generator eluate
to a definite chemical form and its solubility in organic sol-
vents makes [72As]AsI3 a very useful synthon for subsequent
labelling chemistry.
3.4 Apparatus
A schematic representation of the 72Se/72As radionuclide
generator system is shown in Fig. 4. It consists of two Teflon
reactors and the two corresponding polystyrene based ENV
solid phase extraction cartridges. The first cartridge repre-
sents the generator column and the second one is used for
the solid phase extraction based separation of nca [72As]AsI3
from the radionuclide generator eluate. Reservoirs are there
for all the above described necessary solutions and the appa-
ratus can be flushed with nitrogen. This system is well suited
for automation.
4. Conclusion
Following radiochemical separation of 72Se from irradiated
Ge or GeO2 targets, nca 72Se was used to design a con-
venient solid phase extraction radionuclide generator. After
initial reduction of radioselenium, nca Se(0) is fixed on
a polysterene based solid phase extraction column. Macro-
scopic Ge is separated as [GeF6]2−. Depending on the eluent,
72As can be obtained with yields > 60% and a selenium con-
tamination of less than 0.1%.
In addition to radionuclide generator performance, two
other aspects are important. Compared to previously de-
scribed 72Se/72As radionuclide generator designs, the meth-
od has two advantages. (A) it allows an efficient route
to 72As labelling molecules relevant to biochemistry and
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Fig. 4. Scheme of a 72Se/72As radionuclide generator based on solid
phase extraction.
medicine via the labelling synthon [72As]AsI3 and (B) it
represents a convenient technological realisation with rather
low operation costs and easy to automate for routine use.
Systematic chemical investigations on the labelling chem-
istry of no-carrier-added radioarsenic, however, are required
prior to the application of 72As labelled compounds.
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